India "misinterpreted" WHO on vax plants; Germany checks cheap AIDS drug import scheme;

> A parliamentary panel in India says it was "abundantly clear" that the decision to suspend the licenses of three public vaccine-making plants was based on "a major misconception and misinterpretation" of WHO's assessment of them. Story

> German police are investigating pharma distributors suspected of importing cheap AIDS vaccines from Africa and selling them at inflated prices. Story

> Japan has suspended vaccines made by Pfizer and Sanofi-Aventis while regulators investigate the deaths of four children. Item

> Giant robots count and process medications at the UC San Francisco Medical Center. Article

> "The operating environment for pharma is worsening rapidly," says Morgan Stanley, as it downgrades the multinational pharmaceutical companies in Europe. Story

> India may be facing a shortage of professionals in the pharma outsourcing sector. Article

> WuXi PharmaTech will build and operate a cGMP-compliant 25,000-square-foot facility in Shanghai to store and test stability samples for Bristol-Myers Squibb. BMS-WuXi release

> Pharma is among Canadian manufacturing sectors investing in distribution facilities to meet retailers' daily replenishment requirements. Story

> Colorado-based Tolmar has selected Pilgrim Software's Risk, Compliance and Quality Management solution. Pilgrim Software release

> Merck KGaA has appointed Friedhelm Felten head of corporate procurement with responsibility for global purchasing activities. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.